Autopsy report · NCT04774640

Development of a NIPTT for Detecting Copy Number Variations

“Poor rate of eligible subject enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 years 9 months after it had already started.
• Ran for about 3 years 11 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Sequenom, Inc.

Sponsor type

Industry

Conditions

Copy Number Variations

Interventions

MaterniT GENOME

Participants

9

Sites

1

Countries

United States

Trials that died the same way

• Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples
  “Lower than anticipated rate of subject enrollment” (87% match in meaning)
• Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis
  “low-rate of enrollment” (84% match in meaning)
• Prophylactic Phenobarbital After Neonatal Seizures
  “Inadequate rate of enrollment” (83% match in meaning)
• Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
  “Low enrollment rate” (82% match in meaning)
• Effectiveness Study of Santyl Ointment to Treat Pressure Ulcers
  “Low enrollment of qualified subjects” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.